Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis
Jun Li(Fudan University), Matthias Pauschinger(Nuremberg Hospital), Michel Noutsias(Martin Luther University Halle-Wittenberg), Karin Klingel(Universitätsklinikum Tübingen), Heinz Zeichhardt(Charité - Universitätsmedizin Berlin), Sebastian Leschka(University Hospital of Zurich), Lars Husmann, Heinz‐Peter Schultheiß(CS Diagnostics), Wolfgang Poller(Berlin-Brandenburger Centrum für Regenerative Therapien), Peter Schwimmbeck(Charité - Universitätsmedizin Berlin), Carsten Tschöpe(Deutsches Herzzentrum der Charité), Dirk Westermann(University Medical Center Freiburg), Susanne Rutschow(Charité - Universitätsmedizin Berlin)
Cited by 37
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|716
Spatial multi-omic map of human myocardial infarction
|Nature|2022|692
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation
|Circulation|2020|502
Inflammation – Cause or Consequence of Heart Failure or Both?
|Current Heart Failure Reports|2017|457